1. Us2.ai provides a patented, FDA-cleared, and CE-marked clinical decision support solution that generates a complete cardiac echocardiographic report in under two minutes. By analyzing 2D and Doppler echocardiogram images, this AI-powered echocardiography tool provides comprehensive cardiac measurements aligned with international guidelines, streamlining workflows and enabling early diagnosis of heart failure. The solution has unlocked the opportunity for new clinical pathways, extending echocardiography interpretation to primary care settings and even patient home monitoring. It has proven its utility in supporting primary care nurses in identifying patients at risk of heart failure. Successfully deployed at HXIS and showcased at HealthX Startup Day 2023, Us2.ai is advancing to its next stage of discussions for adoption with respective healthcare entities.
2. FathomX’s FXMammo applies AI to enhance and reduce cost mammograph2. y screening, increasing adoption and improving early screening for the number one cancer among women. The aim was to deploy the FXMammo solution in HXIS to showcase on the HCC environment. FathomX had successfully completed the solution deployment in HXIS and demonstrated the AI echo copilot solution at the HealthX Startup Day 2023.
3. iota medtech – iScreen project was hosted at HXIS to allow for testing of iScreen ICH AI model, an AI powered image processing model for the detection and classification of intracranial hemorrhage (ICH). iota medtech successfully met the project exit criteria and is currently working with SingHealth to deploy this AI model in AIMSG under the Test-bedding programme as the next phase.
